Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

VITA 34 AG

V3V
Current price
3.82 EUR +0.02 EUR (+0.53%)
Last closed 3.96 EUR
ISIN DE000A0BL849
Sector Healthcare
Industry Medical Care Facilities
Exchange Frankfurt Exchange
Capitalization 70 536 862 EUR
Yield for 12 month -8.72 %
1Y
3Y
5Y
10Y
15Y
V3V
21.11.2021 - 28.11.2021

VITA 34 AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the company provides biobanking services, such as freezing sperm and storage of adipose tissue and the isolation of cells from the stored materials. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany. Address: Deutscher Platz 5a, Leipzig, Germany, 04103

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.98 EUR

P/E ratio

Dividend Yield

Current Year

+77 956 833 EUR

Last Year

+69 740 522 EUR

Current Quarter

+19 699 118 EUR

Last Quarter

+18 772 481 EUR

Current Year

+26 910 898 EUR

Last Year

+2 766 759 EUR

Current Quarter

+7 212 792 EUR

Last Quarter

+7 043 853 EUR

Key Figures V3V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 3 877 508 EUR
Operating Margin TTM -5.51 %
PE Ratio
Return On Assets TTM -0.82 %
PEG Ratio
Return On Equity TTM -1.04 %
Wall Street Target Price 5.98 EUR
Revenue TTM 79 738 281 EUR
Book Value 1.34 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 6 %
Dividend Yield
Gross Profit TTM 12 582 428 EUR
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -6.7 %
Profit Margin -0.12 %

Dividend Analytics V3V

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

48 %

Dividend History V3V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 05.06.2019
Forward Annual Dividend Yield
Last Split Factor 1481:1440
Payout Ratio
Last Split Date 14.07.2017
Dividend Date

Stock Valuation V3V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.9451
Price Sales TTM 0.8846
Enterprise Value EBITDA 10.0124
Price Book MRQ 3.0815

Financials V3V

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators V3V

For 52 weeks

3.73 EUR 5.97 EUR
50 Day MA 4.53 EUR
Shares Short Prior Month
200 Day MA 4.65 EUR
Short Ratio
Shares Short
Short Percent